CRO

QPS Assay Finder Database Grows 47 New Assays!

For all you assay aficionados out there, we thought you’d be juiced to know — we just added a whopping 47 new assays to the QPS Assay Finder Database: Agomelatine; Albendazole + metabolite; Amphetamine; Apixaban; Apremilast; Atazanavir; Atorvastatin + metabolites; Bosutinib; Bupropion + metabolites; Caffeine + metabolites; Carbamazepine + metabolite; Cetirizine; Chlorzoxazone; Colchicine; Dexamethasone; Dolutegravir;

QPS Assay Finder Database Grows 47 New Assays! Read More »

QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year

For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and continuous contribution to the growth and development of our community, and commitment to the cause and success of the EMSDC, QPS has been named Class IV Supplier of the Year! The

QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year Read More »

Sanjay Mitter new VP and Global Head of Clinical Research Services

Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics, data management, biostatistics, medical writing and publishing. He also oversees clinical monitoring and project management in the US. Sanjay comes to us fresh from a stint as Global Director of Biostatistics,

Sanjay Mitter new VP and Global Head of Clinical Research Services Read More »

qps-neuro

Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016

Join us from July 24-27, 2016 in Toronto, Canada for the Alzheimer’s Association International Conference. QPS neuroscientists will attend the AAIC 2016 and would be pleased to meet you there at our booth#207 to discuss potential and ongoing projects. QPS posters presented: Sunday, July 24, 2016, 9:30 AM to 10:30 AM (Session: P1-02-062, Poster: #12005)

Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016 Read More »

bio-zone

QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!

Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry. In this regard, Daniel Wilffert, a 2016 award nominee from QPS Netherlands, is truly fresh off the starting blocks. He started @QPS Holdings LLC last August and only just defended his

QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone! Read More »

Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!

QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of The Year Award for the Greater Philadelphia area. The only competitive awards program in the world for entrepreneurs and leaders of high-growth companies, the 30 year-old program operates in 145 cities

Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia! Read More »

Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability

Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the magazine teams up with Industry Standard Research (ISR). ISR looks at 27 different performance metrics, as rated by decision-making executives at biopharmaceutical companies. “Real customers provide experiential feedback on their involvement

Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability Read More »

QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel

Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if done well, or can create a road full of potholes if managed incorrectly. On April 11th, Barbara Derler, PhD, heading the EU patient recruitment team from the QPS site in

QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel Read More »

QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug

QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug in subjects with advanced prostate carcinoma. The original enrollment goal was 133 patients to be enrolled in approximately 18 months. The QPS Global Clinical Operations team enrolled 137 patients at

QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug Read More »

SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics

Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition has created new challenges in the industry. To address these challenges and boost productivity, QPS has teamed up with SCIEX, a global leader in life science analytical technologies, to advance a

SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics Read More »

QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells

QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and hepatic stellate cells for research. QPS now has exclusive rights to distribute Samsara’s primary human hepatocytes. At the same time, the two companies will also cooperate to provide specialized non-parenchymal hepatocytes

QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells Read More »

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!

QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated investigational drug in subjects with advanced prostate carcinoma. The original enrollment goal was 133 patients to be enrolled in approximately 18 months. The QPS Global Clinical Operations team enrolled 137

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe! Read More »

QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study

If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse livers – a QPS-developed (LC)-ICP-MS assay may well be what you need. These assays, validated according to FDA, EMA and ICH guidelines, can quantify levels of most ELEMENTS (such as iron,

QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study Read More »

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease

The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias for a six-month public consultation. The EMA considers dementia a key public health priority and sees early stage intervention and prevention of symptomatic disease as particularly worthy goals. This

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease Read More »

Magnesium-Tablet-Form

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database

The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last 100 years in Western countries. For example, in the US it is often below the recommended dietary allowances. Decreased Mg intake and/or low serum Mg have been associated with a number

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database Read More »

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016

On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development and personalized medicine at the Informa-sponsored Early Clinical Development conference, Amba Hotel Marble Arch, London. In her lecture, Professor Diamant will cover the following topics: Definition of a valuable biomarker Which

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016 Read More »

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration

Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled, the investigational site may be located anywhere in the world. This paper will walk you through the three key essential considerations for clinical trials intended to support registration in the

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration Read More »

Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients

Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures – for the tenth time. But we can’t help it. We’re really excited about this one! That’s because we’re proud to provide specialized, collaborative Clinical Development services that help us build

Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients Read More »

Scroll to Top